Malcolm Stewart Buchanan
Griffith University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Malcolm Stewart Buchanan.
Organic Letters | 2009
Liza Fernandez; Malcolm Stewart Buchanan; Anthony Richard Carroll; Yunjiang Feng; Ronald J. Quinn; Vicky M. Avery
With the aim of finding new natural product antimalarials, the novel indole alkaloids flinderole A-C were found to have selective antimalarial activities with IC(50) values between 0.15-1.42 microM. Flinderole A was isolated from the Australian plant Flindersia acuminata and flinderoles B and C from the Papua New Guinean plant F. amboinensis. Flinderoles A-C contain an unprecedented rearranged skeleton compared to their related isomers of the borreverine class of compounds.
Journal of Medicinal Chemistry | 2008
Malcolm Stewart Buchanan; Anthony Richard Carroll; Deborah Wessling; Michael F. Jobling; Vicky M. Avery; Rohan Andrew Davis; Yunjiang Feng; Yafeng Xue; Linda Öster; Thomas Fex; Johanna Deinum; John N. A. Hooper; Ronald J. Quinn
Bioassay-guided fractionation of a CH2Cl2/MeOH extract of the sponge Suberea clavata using the serine protease factor XIa to detect antithrombotic activity led to the isolation of the new marine natural products, clavatadines A and B. Clavatadines A and B inhibited factor XIa with IC50s of 1.3 and 27 microM, respectively. A crystal structure of protein-inhibitor (clavatadine A) complex was obtained and revealed interesting selective binding and irreversible inhibition of factor XIa. The cocrystal structure provides guidance for the design and synthesis of future factor XIa inhibitors as antithrombotic agents.
Journal of Natural Products | 2010
Xinzhou Yang; Rohan Andrew Davis; Malcolm Stewart Buchanan; Sandra Duffy; Vicky M. Avery; David Brian Camp; Ronald J. Quinn
A drug discovery program aimed at identifying new antimalarial leads from a prefractionated natural product library has resulted in the identification of a new bromotyrosine alkaloid, psammaplysin G (1), along with the previously isolated compound, psammaplysin F (2). When tested against two different strains of the parasite Plasmodium falciparum (Dd2 and 3D7), 2 displayed IC(50) values of 1.4 and 0.87 microM, respectively, while 1 showed 98% inhibition at 40 microM against the chloroquine-resistant (Dd2) strain of P. falciparum.
Journal of Natural Products | 2008
Malcolm Stewart Buchanan; Anthony Richard Carroll; Gregory Allen Fechner; Anthony Boyle; Moana Simpson; Rama Addepalli; Vicky M. Avery; John N. A. Hooper; Tony Cheung; Huwei Chen; Ronald J. Quinn
The anticancer target isoprenylcysteine carboxyl methyltransferase (Icmt) was the focus of a natural product high-throughput screening campaign. The Australian marine sponge Pseudoceratina sp. yielded aplysamine 6, a new bromotyrosine derivative with an alpha,beta-unsaturated amide linkage, as the bioactive constituent. Its structure was determined by 1D and 2D NMR spectroscopy.
Journal of Medicinal Chemistry | 2012
Rohan Andrew Davis; Malcolm Stewart Buchanan; Sandra Duffy; Vicky M. Avery; Susan A. Charman; William N. Charman; Karen L. White; David M. Shackleford; Michael D. Edstein; Katherine Thea Andrews; David Brian Camp; Ronald J. Quinn
A new bispyrroloiminoquinone alkaloid, tsitsikammamine C (1), displayed potent in vitro antimalarial activity with IC(50) values of 13 and 18 nM against chloroquine-sensitive (3D7) and chloroquine-resistant (Dd2) Plasmodium falciparum, respectively. Tsitsikammamine C (1) displayed selectivity indices of >200 against HEK293 cells and inhibited both ring and trophozoite stages of the malaria parasite life cycle. Previously reported compounds makaluvamines J (2), G (3), L (4), K (5) and damirones A (6) and B (7) were also isolated from the same marine sponge (Zyzzya sp.). Compounds 2-4 displayed potent growth inhibitory activity (IC(50) < 100 nM) against both P. falciparum lines and only moderate cytotoxicity against HEK293 cells (IC(50) = 1-4 μM). Makaluvamine G (3) was not toxic to mice and suppressed parasite growth in P. berghei infected mice following subcutaneous administration at 8 mg kg(-1) day(-1).
Journal of Natural Products | 2009
Malcolm Stewart Buchanan; Rohan Andrew Davis; Sandra Duffy; Vicky M. Avery; Ronald J. Quinn
Mass-directed isolation of the CH(2)Cl(2)/MeOH extract of Doryphora sassafras resulted in the purification of a new benzylisoquinoline alkaloid, 1-(4-hydroxybenzyl)-6,7-methylenedioxy-2-methylisoquinolinium trifluoroacetate (1), and the known aporphine alkaloid (S)-isocorydine (2). The structures of 1 and 2 were determined by 1D and 2D NMR and MS data analyses. The compounds were isolated during a drug discovery program aimed at identifying new antimalarial leads from a prefractionated natural product library. When tested against two different strains of the parasite Plasmodium falciparum (3D7 and Dd2), 1 displayed IC(50) values of 3.0 and 4.4 microM, respectively. Compound 1 was tested for cytotoxicity toward a human embryonic kidney cell line (HEK293) and displayed no activity at 120 microM.
Journal of Natural Products | 2009
Malcolm Stewart Buchanan; Anthony Richard Carroll; Deborah Wessling; Michael F. Jobling; Vicky M. Avery; Rohan Andrew Davis; Yunjiang Feng; John N. A. Hooper; Ronald J. Quinn
Three new marine alkaloids, clavatadines C-E (1-3), together with the three known compounds aerophobin 1 (4), purealdin L (5), and aplysinamisine II (6) were isolated from extracts of the sponge Suberea clavata by bioassay-guided fractionation using a serine protease factor XIa assay. Their structures were determined by 1D and 2D NMR spectroscopy. Compounds 1-6 exhibited weak inhibition of factor XIa.
Bioorganic & Medicinal Chemistry Letters | 2008
Malcolm Stewart Buchanan; Anthony Richard Carroll; Annette Edser; Melissa Sykes; Gregory Allen Fechner; Paul I. Forster; Gordon P. Guymer; Ronald J. Quinn
A new natural product, lysianadioic acid, was isolated from the plant Lysiana subfalcata as a carboxypeptidase B (CPB) inhibitor. It is a potent inhibitor of CPB with an IC(50) of 0.36 microM. This is the first known example of a small molecule CPB inhibitor isolated from plant origin. Its structure was determined by NMR spectroscopy.
Journal of Organic Chemistry | 2007
Malcolm Stewart Buchanan; Anthony Richard Carroll; Rama Addepalli; Vicky M. Avery; John N. A. Hooper; Ronald J. Quinn
Tetrahedron Letters | 2007
Malcolm Stewart Buchanan; Anthony Richard Carroll; Ronald J. Quinn